High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease.
Bernardo D'OnofrioGiulia VirelliElisa PedrolloMarta CaprioliMarta RivaDaniela RennaAntonio TonuttiNicoletta LucianoAngela CeribelliElisa GremeseMaria De SantisCarlo Francesco SelmiPublished in: Rheumatology advances in practice (2024)
Parvovirus B19 infection manifestations may vary and nearly all patients with positive serum ANA fulfil the classification criteria for SLE. The risk of misclassification in patients with viral infection should not be overlooked.